Cook begins US trials of endovascular AAA (abdominal aortic aneurysm) graft
This article was originally published in Clinica
Cook is to begin US trials of its Zenith endovascular graft system for abdominal aortic aneurysm (AAA). The Bloomington, Indiana-based company is setting up a 15-centre clinical trial of the graft, after being granted an investigational device exemption by the FDA last month.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.